Track Claritev Corporation — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Claritev Corporation CTEV · Stock Open Claritev Corporation in new tab

35.35 USD
EPS
-17.45
P/B
-2.01
ROE
-646.34
Beta
0.79
Target Price
40.50 USD
Claritev Corporation logo

Claritev Corporation

🧾 Earnings Recap – Q2 2026

Claritev's stock surged 21.4% following an earnings report that beat expectations on key metrics including bookings and revenue, driven by strong momentum in the third-party administrator (TPA) segment and expanding opportunities in Medicare Advantage.

  • Bookings exceeded $74 million in the first half of 2026, well on track for the $100 million full year stretch target.
  • The TPA segment led new bookings with multiple 7-figure deals, accounting for roughly 30% of total new bookings and showing immediate progress under new leadership.
  • Revenue and adjusted EBITDA both came in above plan, validating the company’s transformation strategy and operational execution.
  • Growth is supported by increasing deal sizes, improved win rates, and a healthy sales pipeline across core and emerging verticals.
  • Emerging Medicare Advantage opportunities reflect the company’s successful diversification strategy, expanding its addressable market beyond traditional segments.
📅
Loading chart...
Key Metrics
Earnings dateNov. 6, 2026
EPS-17.45
Book Value-17.39
Price to Book-2.01
Debt/Equity31271.65
% Insiders7.399%
Growth
Revenue Growth0.07%
Estimates
Forward P/E4.77
Forward EPS7.33
Target Mean Price40.50

DCF Valuation

Tweak assumptions to recompute fair value for Claritev Corporation (CTEV)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Claritev Corporation Logo Claritev Corporation Analysis (CTEV)

Is Claritev Corporation a good investment? Claritev Corporation (CTEV) is currently trading at 35.35 USD. Market analysts have a consensus price target of 40.50 USD. This suggests a potential upside from current levels.

Earnings Schedule: Claritev Corporation is expected to release its next earnings report on Nov. 6, 2026. The market consensus estimate for Forward EPS is 7.33.

Investor FAQ

Does Claritev Corporation pay a dividend?

No, it does not currently pay a dividend.

What asset class is Claritev Corporation?

Claritev Corporation is classified as a Stock.

When is the next earnings date?

The next earnings date is projected to be Nov. 6, 2026. The company currently has a trailing EPS of -17.45.

Company Profile

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.

Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Sept. 23, 2024 0.030000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion